Traxion Sab De Cv Ord Shs GRPOF

07:33 AM EST, 11/23/2017 (MT Newswires)

[charly90]

07:33 AM EST, 11/23/2017 (MT Newswires) -- Tetra Bio-Pharma (TBP.V) -- a company focused on cannabinoid-based drug development and discovery -- on Wednesday dropped 2.9% to $0.67 apiece in a 52-week range of $0.59 - 0.81. TBP is probably hoping that its shares will turn around for the better over time as it commented on the Canadian Government's proposed approach to the regulation of cannabis.

The company in a statement said that the proposal "further confirms the strategic direction of its business model, and that the company is in an excellent position to commercialize natural health products and drugs post-legalization for both the pet and human markets."

TBP added over the coming months, it will be preparing the implementation of its product launch strategies and preparing for commercialization in accordance with the regulatory framework described in the proposed Cannabis Act.

[keepitrealhomie]

yep. Short term, this probably will continue not to do much. If you want to look into a company that is adressing the medical benefit of cannabis, check out ISOL. They are in the top 5 revenue producing weed stocks. 

[Brootal]

I just want to suggest that everyone look at the history of this stock - last time it ran for like 5 days straight on no news. This stock doesn't need news to move.

[Catalystking519]

Isol trade between .17-.23 for months before the market caught up to their revenue,  $$ rules all and eventually the market reacts.  We need revenue for everyone to see and that won’t be from rx or device thru Sante, these are promising signs but will not produce millions in revenue it’s just facts,  will be years but it will be well worth it once MDs are prescribing PPP001 as a